These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7036169)

  • 1. Enhanced renal allograft survival from azathioprine/steroid modified antibody-dependent cellular cytotoxicity.
    Dumble LJ; Macdonald IM; Kincaid-Smith P; Clunie GJ
    Proc Eur Dial Transplant Assoc; 1981; 18():475-80. PubMed ID: 7036169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithymocyte globulin-induced prolongation of human renal allograft survival in recipients with in vitro steroid-resistant ADCC.
    Dumble LJ; Clunie GJ; Macdonald IM; Bowes LG; Kincaid-Smith P
    Transplant Proc; 1984 Dec; 16(6):1503-5. PubMed ID: 6390854
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
    Wasik M; Gradowska L; Lao M; Rowińska D; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):311-4. PubMed ID: 373680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between ADCC resistance to in vitro steroid and renal allograft failure.
    Dumble LJ; Macdonald IM; Kincaid-Smith P; Clunie GJ
    Transplant Proc; 1981 Sep; 13(3):1569-71. PubMed ID: 7029817
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid sensitivity of chronic uraemic and renal transplant patients measured by the antibody dependent cellular cytotoxicity reaction.
    Petri I; Csajbók E; Kiss E; Szenohradszky P; Kaiser G; Gál G
    Haematologia (Budap); 1985; 18(4):225-32. PubMed ID: 3915294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
    Dickmeiss E
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential changes in NK and ADCC effector cell function after organ transplantation in man.
    Hegarty JH; Ramsden CW; Dowd PS; Giles GR; Guillou PJ
    Biomed Pharmacother; 1983; 37(6):266-70. PubMed ID: 6367846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period.
    Renna E; Sansonetti P; Nesci C; Famulari A; Cortesini R
    Proc Eur Dial Transplant Assoc; 1977; 14():336-41. PubMed ID: 341135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) in 229 sera from human renal allograft recipients.
    Descamps B; Gagnon R; van der Gaag R; Feuillet MN; Crosnier J
    J Clin Lab Immunol; 1979 Nov; 2(4):303-9. PubMed ID: 395307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic characterization of the rejection of the allogenic transplanted kidney in pigs with and without immunosuppression].
    Werner M; Keitel R; Schürer KD; Otto U; Klötzer B; Kothe W; Sauer H; Ambrosius H
    Z Exp Chir Transplant Kunstliche Organe; 1986; 19(5):279-92. PubMed ID: 3538686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas JM; Verbanac KM; Smith JP; Kasten-Jolly J; Gross U; Rebellato LM; Haisch CE; Carver FM; Thomas FT
    Transplantation; 1995 Jan; 59(2):245-55. PubMed ID: 7839448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients.
    Prince HE; Ettenger RB; Dorey FJ; Fine RN; Fahey JL
    J Clin Immunol; 1984 Jul; 4(4):312-8. PubMed ID: 6378956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients.
    Prince HE; Ettenger RB; Dorey FJ; Fine RN; Fahey JL
    Transplant Proc; 1984 Dec; 16(6):1475-7. PubMed ID: 6390849
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of antibody dependent cellular cytotoxicity (ADCC). III. Preliminary findings concerning the influence of immunosuppressive drugs.
    Wasik M; Rancewicz Z; Morzycka M; Juskowa J; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):315-8. PubMed ID: 749782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse presensitization to renal transplants. Detection by utilization of a D locus antigen-defined lymphoblastoid cell panel as targets in antibody-dependent cell-mediated cytotoxicity assays.
    Suthanthiran M; Fotino M; Cheigh JS; Rubin AL; Novogrodsky A; Stenzel KH
    Transplantation; 1979 May; 27(5):333-7. PubMed ID: 373190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.